Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	ARM-type_fold	IPO5 THADA NBEAL1 XPO6 ARFGEF2 ARFGEF1 CUL9 PRKDC TANGO6 XPO7	6.56e-06	339	92	10	IPR016024
Domain	ARM-like	IPO5 ARID1B XPO6 ARFGEF2 ARFGEF1 CUL9 PRKDC TANGO6 XPO7	7.36e-06	270	92	9	IPR011989
Domain	-	IPO5 ARID1B XPO6 ARFGEF2 ARFGEF1 CUL9 PRKDC TANGO6	1.39e-05	222	92	8	1.25.10.10
Domain	TSP_1	CCN6 CCN5 ADAMTS19 ADAMTS6 THSD7B	1.46e-05	63	92	5	PF00090
Domain	TSP1	CCN6 CCN5 ADAMTS19 ADAMTS6 THSD7B	1.70e-05	65	92	5	SM00209
Domain	TSP1_rpt	CCN6 CCN5 ADAMTS19 ADAMTS6 THSD7B	1.70e-05	65	92	5	IPR000884
Domain	TSP1	CCN6 CCN5 ADAMTS19 ADAMTS6 THSD7B	1.70e-05	65	92	5	PS50092
Domain	-	TLN1 TLN2	2.40e-05	2	92	2	1.20.1420.10
Domain	VBS	TLN1 TLN2	2.40e-05	2	92	2	PF08913
Domain	Vinculin-bd_dom	TLN1 TLN2	2.40e-05	2	92	2	IPR015009
Domain	Talin_cent	TLN1 TLN2	2.40e-05	2	92	2	IPR015224
Domain	Talin_middle	TLN1 TLN2	2.40e-05	2	92	2	PF09141
Domain	IMPORTIN_B_NT	IPO5 XPO6 XPO7	4.05e-05	14	92	3	PS50166
Domain	Talin-1	TLN1 TLN2	7.18e-05	3	92	2	IPR015710
Domain	Importin-beta_N	IPO5 XPO6 XPO7	7.48e-05	17	92	3	IPR001494
Domain	ILWEQ_dom	TLN1 TLN2	1.43e-04	4	92	2	IPR002558
Domain	ILWEQ	TLN1 TLN2	1.43e-04	4	92	2	SM00307
Domain	DCB_dom	ARFGEF2 ARFGEF1	1.43e-04	4	92	2	IPR032629
Domain	FERM_f0	TLN1 TLN2	1.43e-04	4	92	2	PF16511
Domain	ILWEQ	TLN1 TLN2	1.43e-04	4	92	2	PD011820
Domain	-	TLN1 TLN2	1.43e-04	4	92	2	1.20.1410.10
Domain	Sec7_C	ARFGEF2 ARFGEF1	1.43e-04	4	92	2	IPR015403
Domain	DUF1981	ARFGEF2 ARFGEF1	1.43e-04	4	92	2	PF09324
Domain	I_LWEQ	TLN1 TLN2	1.43e-04	4	92	2	PF01608
Domain	I_LWEQ	TLN1 TLN2	1.43e-04	4	92	2	PS50945
Domain	Sec7_N	ARFGEF2 ARFGEF1	1.43e-04	4	92	2	IPR032691
Domain	Sec7_N	ARFGEF2 ARFGEF1	1.43e-04	4	92	2	PF12783
Domain	FERM_f0	TLN1 TLN2	1.43e-04	4	92	2	IPR032425
Domain	DCB	ARFGEF2 ARFGEF1	1.43e-04	4	92	2	PF16213
Domain	ArfGap	ARFGAP2 AGAP5 AGAP9	3.85e-04	29	92	3	SM00105
Domain	ARFGAP	ARFGAP2 AGAP5 AGAP9	3.85e-04	29	92	3	PS50115
Domain	ArfGap	ARFGAP2 AGAP5 AGAP9	3.85e-04	29	92	3	PF01412
Domain	ArfGAP	ARFGAP2 AGAP5 AGAP9	3.85e-04	29	92	3	IPR001164
Domain	Vinculin/catenin	TLN1 TLN2	4.96e-04	7	92	2	IPR006077
Domain	Insulin_GF-bd_Cys-rich_CS	CCN6 CCN5	1.28e-03	11	92	2	IPR017891
Domain	IGFBP_N_1	CCN6 CCN5	1.53e-03	12	92	2	PS00222
Domain	IRS	TLN1 TLN2	2.10e-03	14	92	2	PF02174
Domain	IRS_PTB	TLN1 TLN2	2.10e-03	14	92	2	IPR002404
Domain	PLAC	ADAMTS19 ADAMTS6	2.10e-03	14	92	2	PF08686
Domain	-	ARFGEF2 ARFGEF1	2.42e-03	15	92	2	1.10.1000.11
Domain	IBN_N	XPO6 XPO7	2.42e-03	15	92	2	PF03810
Domain	Sec7	ARFGEF2 ARFGEF1	2.42e-03	15	92	2	PF01369
Domain	Sec7_alpha_orthog	ARFGEF2 ARFGEF1	2.42e-03	15	92	2	IPR023394
Domain	Chemokine_rcpt	CCR5 CCR6	2.75e-03	16	92	2	IPR000355
Domain	IBN_N	XPO6 XPO7	2.75e-03	16	92	2	SM00913
Domain	SEC7	ARFGEF2 ARFGEF1	2.75e-03	16	92	2	PS50190
Domain	Sec7	ARFGEF2 ARFGEF1	2.75e-03	16	92	2	SM00222
Domain	Sec7_dom	ARFGEF2 ARFGEF1	2.75e-03	16	92	2	IPR000904
Domain	IB	CCN6 CCN5	3.49e-03	18	92	2	SM00121
Domain	PLAC	ADAMTS19 ADAMTS6	3.89e-03	19	92	2	PS50900
Domain	PLAC	ADAMTS19 ADAMTS6	3.89e-03	19	92	2	IPR010909
Domain	IGFBP	CCN6 CCN5	4.30e-03	20	92	2	PF00219
Domain	IGFBP-like	CCN6 CCN5	4.30e-03	20	92	2	IPR000867
Domain	IGFBP_N_2	CCN6 CCN5	4.30e-03	20	92	2	PS51323
Pubmed	Evolution of Human Brain Size-Associated NOTCH2NL Genes Proceeds toward Reduced Protein Levels.	NOTCH2NLB NOTCH2NLA NOTCH2NLC NOTCH2	5.45e-11	4	96	4	32330268
Pubmed	Human-Specific NOTCH2NL Genes Affect Notch Signaling and Cortical Neurogenesis.	NOTCH2NLB NOTCH2NLA NOTCH2NLC NOTCH2	2.72e-10	5	96	4	29856954
Pubmed	Characterization of the EGFR interactome reveals associated protein complex networks and intracellular receptor dynamics.	IPO5 THADA XPO6 FDPS ARFGEF1 RNF213 PRKDC XPO7	4.50e-08	183	96	8	23956138
Pubmed	Evolution and cell-type specificity of human-specific genes preferentially expressed in progenitors of fetal neocortex.	NOTCH2NLB NOTCH2NLA NOTCH2NLC	8.14e-08	4	96	3	29561261
Pubmed	Human-Specific NOTCH2NL Genes Expand Cortical Neurogenesis through Delta/Notch Regulation.	NOTCH2NLB NOTCH2NLA NOTCH2NLC	2.03e-07	5	96	3	29856955
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	CLCN6 ZNF608 XPO6 SYNE1 TLN1 TLN2 AKAP11 KAT6B	2.20e-07	225	96	8	12168954
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	ARFGAP2 THADA APBB2 ARFGEF2 ARFGEF1 RNF213 CEP131 GPRC5C PRKDC PCDH10 NOTCH2 XPO7	1.60e-06	777	96	12	35844135
Pubmed	O-fucosylation of thrombospondin type 1 repeats restricts epithelial to mesenchymal transition (EMT) and maintains epiblast pluripotency during mouse gastrulation.	CCN6 CCN5 ADAMTS19 ADAMTS6 THSD7B	2.14e-06	75	96	5	20637190
Pubmed	Identification of different proteins binding to Na, K-ATPase α1 in LPS-induced ARDS cell model by proteomic analysis.	TKT PSMA4 TLN1 RNF213 PRKDC UQCRC1	3.10e-06	144	96	6	35681168
Pubmed	Targeted ablation of PINCH1 and PINCH2 from murine myocardium results in dilated cardiomyopathy and early postnatal lethality.	TLN1 TLN2 LIMS2	7.26e-06	14	96	3	19652092
Pubmed	Molecular characterization of CCR6: involvement of multiple domains in ligand binding and receptor signaling.	CCR5 CCR6	7.54e-06	2	96	2	15591779
Pubmed	Arf guanine nucleotide-exchange factors BIG1 and BIG2 regulate nonmuscle myosin IIA activity by anchoring myosin phosphatase complex.	ARFGEF2 ARFGEF1	7.54e-06	2	96	2	23918382
Pubmed	Regulation of brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1) and BIG2 activity via PKA and protein phosphatase 1gamma.	ARFGEF2 ARFGEF1	7.54e-06	2	96	2	17360629
Pubmed	Potential roles of CCR5(+) CCR6(+) dendritic cells induced by nasal ovalbumin plus Flt3 ligand expressing adenovirus for mucosal IgA responses.	CCR5 CCR6	7.54e-06	2	96	2	23565250
Pubmed	Identification and localization of two brefeldin A-inhibited guanine nucleotide-exchange proteins for ADP-ribosylation factors in a macromolecular complex.	ARFGEF2 ARFGEF1	7.54e-06	2	96	2	10716990
Pubmed	Membrane association of the Arabidopsis ARF exchange factor GNOM involves interaction of conserved domains.	ARFGEF2 ARFGEF1	7.54e-06	2	96	2	18203920
Pubmed	Up-regulation of CCR5 and CCR6 on distinct subpopulations of antigen-activated CD4+ T lymphocytes.	CCR5 CCR6	7.54e-06	2	96	2	11751947
Pubmed	Novel CD8 T cell alloreactivities in CCR5-deficient recipients of class II MHC disparate kidney grafts.	IGHM CCR5	7.54e-06	2	96	2	25172484
Pubmed	Redundant roles of BIG2 and BIG1, guanine-nucleotide exchange factors for ADP-ribosylation factors in membrane traffic between the trans-Golgi network and endosomes.	ARFGEF2 ARFGEF1	7.54e-06	2	96	2	18417613
Pubmed	Both Talin-1 and Talin-2 correlate with malignancy potential of the human hepatocellular carcinoma MHCC-97 L cell.	TLN1 TLN2	7.54e-06	2	96	2	26822056
Pubmed	Extracellular rigidity sensing by talin isoform-specific mechanical linkages.	TLN1 TLN2	7.54e-06	2	96	2	26523364
Pubmed	Disruption of the ARID1B and ADAMTS6 loci due to a t(5;6)(q12.3;q25.3) in a patient with developmental delay.	ARID1B ADAMTS6	7.54e-06	2	96	2	25250687
Pubmed	New isoform-specific monoclonal antibodies reveal different sub-cellular localisations for talin1 and talin2.	TLN1 TLN2	7.54e-06	2	96	2	22306379
Pubmed	Purification and cloning of a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP-ribosylation factors.	ARFGEF2 ARFGEF1	7.54e-06	2	96	2	10212200
Pubmed	Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	THADA SYNE1 CECR2 THSD7B TANGO6	9.72e-06	102	96	5	11214970
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	SOX6 IPO5 USP2 SYNE1 APBB2 ARFGEF2 CUL9 TLN2 PRKDC UQCRC1 MERTK ZNF439 IMMT RECK	1.17e-05	1285	96	14	35914814
Pubmed	Combinatorial CRISPR screen identifies fitness effects of gene paralogues.	IPO5 ARID1B ARFGEF2 ARFGEF1 ALAS1 XPO7	1.34e-05	186	96	6	33637726
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	IPO5 SF3A1 TLN1 NUMA1 CUL9 PRKDC UQCRC1 IMMT ITPR3 XPO7	1.35e-05	653	96	10	22586326
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	AGAP5 ARID1B ZNF608 FDPS CECR2 MED12L AKAP11 AGAP9 KAT6B	1.63e-05	529	96	9	14621295
Pubmed	Transcriptional fates of human-specific segmental duplications in brain.	NOTCH2NLB NOTCH2NLA NOTCH2NLC	1.91e-05	19	96	3	30228200
Pubmed	Type I gamma phosphatidylinositol phosphate kinase targets and regulates focal adhesions.	TLN1 TLN2	2.26e-05	3	96	2	12422220
Pubmed	Interaction of phosphodiesterase 3A with brefeldin A-inhibited guanine nucleotide-exchange proteins BIG1 and BIG2 and effect on ARF1 activity.	ARFGEF2 ARFGEF1	2.26e-05	3	96	2	19332778
Pubmed	Abnormal chemokine receptor profile on circulating T lymphocytes from nonallergic asthma patients.	CCR5 CCR6	2.26e-05	3	96	2	25178112
Pubmed	Differential expression of the CCN family member WISP-1, WISP-2 and WISP-3 in human colorectal cancer and the prognostic implications.	CCN6 CCN5	2.26e-05	3	96	2	20372786
Pubmed	Specific functions of BIG1 and BIG2 in endomembrane organization.	ARFGEF2 ARFGEF1	2.26e-05	3	96	2	20360857
Pubmed	AMY-1 (associate of Myc-1) localization to the trans-Golgi network through interacting with BIG2, a guanine-nucleotide exchange factor for ADP-ribosylation factors.	ARFGEF2 ARFGEF1	2.26e-05	3	96	2	16866877
Pubmed	Chemokine receptor CCR2 but not CCR5 or CCR6 mediates the increase in pulmonary dendritic cells during allergic airway inflammation.	CCR5 CCR6	2.26e-05	3	96	2	17404315
Pubmed	Differential expression and prognostic implications of the CCN family members WISP-1, WISP-2, and WISP-3 in human breast cancer.	CCN6 CCN5	2.26e-05	3	96	2	17406949
Pubmed	Critical role for mouse marginal zone B cells in PF4/heparin antibody production.	IGHM NOTCH2	2.26e-05	3	96	2	23460609
Pubmed	Glycogen formation via the pentose phosphate pathway in mice in vivo.	TKT RBKS	2.26e-05	3	96	2	13405914
Pubmed	Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cells.	TLN1 TLN2	2.26e-05	3	96	2	18792400
Pubmed	Arginylation-dependent regulation of a proteolytic product of talin is essential for cell-cell adhesion.	TLN1 TLN2	2.26e-05	3	96	2	22665520
Pubmed	Involvement of BIG1 and BIG2 in regulating VEGF expression and angiogenesis.	ARFGEF2 ARFGEF1	2.26e-05	3	96	2	31199673
Pubmed	An essential role for talin during alpha(M)beta(2)-mediated phagocytosis.	TLN1 TLN2	2.26e-05	3	96	2	17202407
Pubmed	Interferon-gamma-mediated site-specific clearance of alphavirus from CNS neurons.	IGHM PRKDC	2.26e-05	3	96	2	11452126
Pubmed	Enhancement of β-catenin activity by BIG1 plus BIG2 via Arf activation and cAMP signals.	ARFGEF2 ARFGEF1	2.26e-05	3	96	2	27162341
Pubmed	The Sec7 guanine nucleotide exchange factor GBF1 regulates membrane recruitment of BIG1 and BIG2 guanine nucleotide exchange factors to the trans-Golgi network (TGN).	ARFGEF2 ARFGEF1	2.26e-05	3	96	2	23386609
Pubmed	Mechanotransduction in talin through the interaction of the R8 domain with DLC1.	TLN1 TLN2	2.26e-05	3	96	2	30028837
Pubmed	Vinculin and talin: focus on the myocardium.	TLN1 TLN2	2.26e-05	3	96	2	19952892
Pubmed	Do DNA repair genes OGG1, XRCC3 and XRCC7 have an impact on susceptibility to bladder cancer in the North Indian population?	PRKDC OGG1	2.26e-05	3	96	2	19815090
Pubmed	Immunodeficient and immunosuppressed mice as models to test anti-Pneumocystis carinii drugs.	IGHM PRKDC	2.26e-05	3	96	2	9021175
Pubmed	Talin depletion reveals independence of initial cell spreading from integrin activation and traction.	TLN1 TLN2	2.26e-05	3	96	2	19160486
Pubmed	Talin and vinculin are downregulated in atherosclerotic plaque; Tampere Vascular Study.	TLN1 TLN2	2.26e-05	3	96	2	27816808
Pubmed	WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors.	CCN6 CCN5	2.26e-05	3	96	2	9843955
Pubmed	A C-terminal sequence in the guanine nucleotide exchange factor Sec7 mediates Golgi association and interaction with the Rsp5 ubiquitin ligase.	ARFGEF2 ARFGEF1	2.26e-05	3	96	2	18832381
Pubmed	The effects of RANTES/CCR5 promoter polymorphisms on HIV disease progression in HIV-infected Koreans.	CCR5 CCR6	2.26e-05	3	96	2	18218038
Pubmed	Cytoskeletal proteins talin and vinculin in integrin-mediated adhesion.	TLN1 TLN2	2.26e-05	3	96	2	15494027
Pubmed	Vinculin controls talin engagement with the actomyosin machinery.	TLN1 TLN2	2.26e-05	3	96	2	26634421
Pubmed	Clinical significance and prospective molecular mechanism of C‑C motif chemokine receptors in patients with early‑stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy.	CCR5 CCR6	2.26e-05	3	96	2	31432181
Pubmed	Cooperation between physiological defenses and immune resistance produces asymptomatic carriage of a lethal bacterial pathogen.	IGHM PRKDC	2.26e-05	3	96	2	37352357
Pubmed	Loss of mouse cardiomyocyte talin-1 and talin-2 leads to β-1 integrin reduction, costameric instability, and dilated cardiomyopathy.	TLN1 TLN2	2.26e-05	3	96	2	28698364
Pubmed	Distinct functions for Arf guanine nucleotide exchange factors at the Golgi complex: GBF1 and BIGs are required for assembly and maintenance of the Golgi stack and trans-Golgi network, respectively.	ARFGEF2 ARFGEF1	2.26e-05	3	96	2	18003980
Pubmed	ABCE1 is a highly conserved RNA silencing suppressor.	STARD9 FDPS SF3A1 NUMA1 IMMT SDHB	2.26e-05	204	96	6	25659154
Pubmed	The E3 ubiquitin ligase and RNA-binding protein ZNF598 orchestrates ribosome quality control of premature polyadenylated mRNAs.	IPO5 TKT PSMA4 PRKDC IMMT NOTCH2 XPO7	3.09e-05	320	96	7	28685749
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	IPO5 XPO6 SF3A1 TLN1 MED12L ARFGEF2 TLN2 TNFAIP2 PRKDC	3.45e-05	582	96	9	20467437
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	IPO5 THADA TKT STARD9 SYNE1 SF3A1 PSMA4 TLN1 NUMA1 TLN2 PRKDC UQCRC1 IMMT SDHB	3.65e-05	1425	96	14	30948266
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	IPO5 CLCN6 TKT SF3A1 TLN1 RNF213 ALAS1 UQCRC1 IMMT NOTCH2 SDHB TMPRSS11B TMED3 XPO7	4.43e-05	1451	96	14	30550785
Pubmed	Granzyme B directly and efficiently cleaves several downstream caspase substrates: implications for CTL-induced apoptosis.	NUMA1 PRKDC	4.51e-05	4	96	2	9586635
Pubmed	Chemokine receptor CXCR3 agonist prevents human T-cell migration in a humanized model of arthritic inflammation.	CCR5 PRKDC	4.51e-05	4	96	2	22392992
Pubmed	Human NB-2 of the contactin subgroup molecules: chromosomal localization of the gene (CNTN5) and distinct expression pattern from other subgroup members.	ARFGEF2 ARFGEF1	4.51e-05	4	96	2	11013081
Pubmed	B cell-mediated antigen presentation is required for the pathogenesis of acute cardiac allograft rejection.	IGHM PRKDC	4.51e-05	4	96	2	17114442
Pubmed	Interaction of FK506-binding protein 13 with brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1): effects of FK506.	ARFGEF2 ARFGEF1	4.51e-05	4	96	2	12606707
Pubmed	Protein kinase A-anchoring (AKAP) domains in brefeldin A-inhibited guanine nucleotide-exchange protein 2 (BIG2).	ARFGEF2 ARFGEF1	4.51e-05	4	96	2	12571360
Pubmed	Clearance of Staphylococcus aureus nasal carriage is T cell dependent and mediated through interleukin-17A expression and neutrophil influx.	IGHM PRKDC	4.51e-05	4	96	2	23529621
Pubmed	Homeostatic regulation of intestinal villous epithelia by B lymphocytes.	IGHM PRKDC	4.51e-05	4	96	2	11884426
Pubmed	Effects of brefeldin A-inhibited guanine nucleotide-exchange (BIG) 1 and KANK1 proteins on cell polarity and directed migration during wound healing.	ARFGEF2 ARFGEF1	4.51e-05	4	96	2	22084092
Pubmed	Vinculin regulates assembly of talin: β3 integrin complexes.	TLN1 TLN2	4.51e-05	4	96	2	24446374
Pubmed	Impaired lung dendritic cell activation in CCR2 knockout mice.	CCR5 CCR6	4.51e-05	4	96	2	15466386
Pubmed	Rap1 binding to the talin 1 F0 domain makes a minimal contribution to murine platelet GPIIb-IIIa activation.	TLN1 TLN2	4.51e-05	4	96	2	30242097
Pubmed	Structural diversity in integrin/talin interactions.	TLN1 TLN2	4.51e-05	4	96	2	21134644
Pubmed	Endothelial cell talin1 is essential for embryonic angiogenesis.	TLN1 TLN2	4.51e-05	4	96	2	21081121
Pubmed	Intrasteric inhibition mediates the interaction of the I/LWEQ module proteins Talin1, Talin2, Hip1, and Hip12 with actin.	TLN1 TLN2	4.51e-05	4	96	2	15581353
Pubmed	T lymphocyte recruitment into renal cell carcinoma tissue: a role for chemokine receptors CXCR3, CXCR6, CCR5, and CCR6.	CCR5 CCR6	4.51e-05	4	96	2	22079021
Pubmed	Alterations in the brain interactome of the intrinsically disordered N-terminal domain of the cellular prion protein (PrPC) in Alzheimer's disease.	IPO5 WDR91 SUOX FDPS TLN1 TLN2 UQCRC1	4.62e-05	341	96	7	29791485
Pubmed	SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB.	IPO5 TKT SF3A1 IGHM TLN1 NUMA1 SCP2 UQCRC1 IMMT	4.77e-05	607	96	9	39147351
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	THADA SSU72 XPO6 TLN1 ARFGEF2 CUL9 TLN2 CEP131 TNFAIP2 PRKDC NOTCH2 ITPR3	5.35e-05	1105	96	12	35748872
Pubmed	Adoptive cell therapy with tumor-specific Th9 cells induces viral mimicry to eliminate antigen-loss-variant tumor cells.	CCR5 CCR6 PRKDC	7.07e-05	29	96	3	34678150
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	IPO5 ARID1B TKT SYNE1 TLN1 MED12L TRIM63 NOTCH2	7.26e-05	497	96	8	23414517
Pubmed	Assignment of Na,K-ATPase beta 2-subunit gene (Atpb-2) to mouse chromosome 11.	ASGR1 ATP1B2	7.50e-05	5	96	2	1971252
Pubmed	Talin1 regulates integrin turnover to promote embryonic epithelial morphogenesis.	TLN1 TLN2	7.50e-05	5	96	2	21670148
Pubmed	MyD88 is required for the formation of long-term humoral immunity to virus infection.	IGHM PRKDC	7.50e-05	5	96	2	17404295
Pubmed	Assignment of Amog (adhesion molecule on glia) gene to mouse chromosome 11 near Zfp-3 and Asgr-1,2 and to human chromosome 17.	ASGR1 ATP1B2	7.50e-05	5	96	2	1699290
Pubmed	A role for antibody and Fc receptor in the clearance of Brugia malayi microfilariae.	IGHM PRKDC	7.50e-05	5	96	2	11920579
Pubmed	PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice.	IGHM PRKDC	7.50e-05	5	96	2	21300912
Pubmed	B cell production of tumor necrosis factor in response to Pneumocystis murina infection in mice.	IGHM PRKDC	7.50e-05	5	96	2	24002064
Pubmed	Kindlin-2 cooperates with talin to activate integrins and induces cell spreading by directly binding paxillin.	TLN1 TLN2	7.50e-05	5	96	2	26821125
Pubmed	γδ T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation.	CCR5 CCR6	7.50e-05	5	96	2	27569912
Pubmed	CCL9 is secreted by the follicle-associated epithelium and recruits dome region Peyer's patch CD11b+ dendritic cells.	CCR5 CCR6	7.50e-05	5	96	2	12960300
Pubmed	The resolution of relapsing fever borreliosis requires IgM and is concurrent with expansion of B1b lymphocytes.	IGHM PRKDC	7.50e-05	5	96	2	12646649
Pubmed	Clustering of alpha(5)beta(1) integrins determines adhesion strength whereas alpha(v)beta(3) and talin enable mechanotransduction.	TLN1 TLN2	7.50e-05	5	96	2	19805288
Interaction	FPR1 interactions	THADA DYM XPO6 ARFGEF2 ARFGEF1 RNF213 PRKDC XPO7	2.84e-07	147	89	8	int:FPR1
Interaction	OPALIN interactions	THADA DYM XPO6 ARFGEF2 ARFGEF1 RNF213 GPRC5C PRKDC XPO7	3.62e-07	209	89	9	int:OPALIN
Interaction	CD244 interactions	ARFGEF2 ARFGEF1 RNF213 TNFAIP2 IMMT	1.26e-06	43	89	5	int:CD244
Interaction	GPR17 interactions	THADA DYM XPO6 ARFGEF2 ARFGEF1 RNF213 TNFAIP2 PRKDC XPO7	4.45e-06	283	89	9	int:GPR17
Interaction	VASN interactions	THADA SF3A1 NOTCH2NLA ARFGEF2 PRKDC NOTCH2 XPO7	6.96e-06	160	89	7	int:VASN
Interaction	SIGLECL1 interactions	THADA DYM XPO6 ARFGEF2 ARFGEF1 RNF213	1.08e-05	113	89	6	int:SIGLECL1
Interaction	VSIG2 interactions	THADA DYM XPO6 XPO7	1.16e-05	32	89	4	int:VSIG2
Interaction	C3orf18 interactions	THADA DYM XPO6 ARFGEF2 PRKDC XPO7	1.20e-05	115	89	6	int:C3orf18
Interaction	FAM234A interactions	THADA XPO6 ARFGEF2 ARFGEF1 PRKDC XPO7	2.02e-05	126	89	6	int:FAM234A
Interaction	CCL3L1 interactions	WNT5A TLN1 TLN2 CCR5	2.10e-05	37	89	4	int:CCL3L1
Interaction	EDNRB interactions	THADA ARFGEF2 ARFGEF1 XPO7	2.60e-05	39	89	4	int:EDNRB
Interaction	NPTN interactions	THADA NBEAL1 XPO6 ARFGEF2 ARFGEF1 RNF213 TNFAIP2 XPO7	3.19e-05	278	89	8	int:NPTN
Interaction	GPR182 interactions	THADA DYM XPO6 ARFGEF2 ARFGEF1 RNF213 GPRC5C TNFAIP2 PRKDC XPO7	3.22e-05	455	89	10	int:GPR182
Interaction	MGARP interactions	THADA ARFGEF2 ARFGEF1 RNF213 TNFAIP2 PRKDC IMMT	5.74e-05	222	89	7	int:MGARP
Interaction	SUMO2 interactions	SOX6 IPO5 TKT SF3A1 TLN1 NUMA1 TRIM63 RNF213 ALAS1 PRKDC MERTK	5.79e-05	591	89	11	int:SUMO2
Interaction	CD40 interactions	THADA DYM XPO6 ARFGEF2 ARFGEF1 RNF213	6.00e-05	153	89	6	int:CD40
Interaction	MFSD4A interactions	THADA ARFGEF2 ARFGEF1 RNF213 TNFAIP2 IMMT XPO7	6.24e-05	225	89	7	int:MFSD4A
Interaction	CCN6 interactions	CCN6 APBB2 NOTCH2	7.66e-05	19	89	3	int:CCN6
Interaction	TMEM9B interactions	ARFGEF2 ARFGEF1 RNF213 TNFAIP2 NOTCH2	1.33e-04	111	89	5	int:TMEM9B
Interaction	LRRC25 interactions	THADA ARFGEF2 ARFGEF1 TNFAIP2 PRKDC XPO7	1.71e-04	185	89	6	int:LRRC25
GeneFamily	CYR61/CTGF/NOV matricellular proteins	CCN6 CCN5	2.07e-04	6	68	2	1046
GeneFamily	ArfGAPs	ARFGAP2 AGAP5 AGAP9	2.56e-04	33	68	3	395
GeneFamily	Exportins	XPO6 XPO7	2.89e-04	7	68	2	547
GeneFamily	CD molecules\|C-C motif chemokine receptors	CCR5 CCR6	6.15e-04	10	68	2	1091
GeneFamily	X-linked mental retardation\|Rho GTPase activating proteins\|BAR-PH domain containing	AGAP5 AGAP9	1.83e-03	17	68	2	1291
GeneFamily	ADAM metallopeptidases with thrombospondin type 1 motif	ADAMTS19 ADAMTS6	2.29e-03	19	68	2	50
Coexpression	GSE18281_SUBCAPSULAR_VS_PERIMEDULLARY_CORTICAL_REGION_OF_THYMUS_UP	DYM SUOX SYNE1 SCP2 CCR6 MERTK RECK ITPR3	5.37e-07	200	92	8	M7235
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANO2 ZNF608 ADAMTS6 THSD7B ATP1B2 PCDH10	3.04e-06	185	96	6	16e9ccea0e3b95d90dc48ef74206c805681dac0b
ToppCell	Control-Endothelial-Endothelial-Artery\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SOX6 ADAMTS6 TLN2 MERTK PCDH10 LIMS2	3.13e-06	186	96	6	2d3a975d2bf92e18e3410dd413fc9f84831d82de
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	USP2 ADAMTS6 STARD9 SYNE1 ADGRL3 LIMS2	4.49e-06	198	96	6	c12e7511628db819a52959bb68580e27c00c2e41
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial\|GW09 / Sample Type, Dataset, Time_group, and Cell type.	ADAMTS6 MPDZ GPRC5C NOTCH2	3.14e-05	83	96	4	7893ce9fbf34c6250dca9c265fe9b2d4cb889ade
ToppCell	facs-Marrow-Granulocytes-18m-Myeloid-granulocyte_monocyte_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	USP2 FDPS ALAS1 PTPRU TMED3	3.46e-05	171	96	5	fea6ef6bbfebea2dd0f0360c7db7a5e858f15958
ToppCell	facs-Marrow-Granulocytes-18m-Myeloid-granulocyte_monocyte_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	USP2 FDPS ALAS1 PTPRU TMED3	3.46e-05	171	96	5	f15594fd4d709920733de9376a391dedc62b65de
ToppCell	P15-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SOX6 AKAP11 SRPX TNFAIP2 XPO7	3.86e-05	175	96	5	085cceb1fc2c4ae2f27e85cea5702defecc2cf44
ToppCell	COVID-19_Moderate-B_intermediate\|COVID-19_Moderate / disease group, cell group and cell class	ZNF608 ADAMTS6 IGHM CCR6 SP140	4.07e-05	177	96	5	68e3d12a0c048a2d0f1b9680c7338a35855bba30
ToppCell	10x5'v1-week_12-13-Lymphocytic_B-B_lineage-naive_B_cell\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	ADAMTS6 IGHM CCR6 SP140 LIMS2	4.07e-05	177	96	5	325c10674b18727ddd50bf088a9c6f4ef29aa809
ToppCell	BAL-Mild-cDC_4\|Mild / Compartment, Disease Groups and Clusters	WDR91 SUOX STARD9 CUL9 ITPR3	4.30e-05	179	96	5	68511e87b12b8253de7771e5ccfc5869248b8450
ToppCell	Leuk-UTI-Lymphocyte-B-B_intermediate\|Leuk-UTI / Disease, Lineage and Cell Type	ZNF608 ADAMTS6 IGHM CCR6 SP140	4.30e-05	179	96	5	01933f6fa94d7032ed403a6cae6985cafa820043
ToppCell	COVID-19_Moderate-B_intermediate\|World / disease group, cell group and cell class	ZNF608 ADAMTS6 IGHM CCR6 SP140	4.41e-05	180	96	5	bd81b87a6dc81e5ab4a6c948eb0c80f14401a6a7
ToppCell	RA-07._Pericyte\|RA / Chamber and Cluster_Paper	NBEAL1 APBB2 GPRC5C THSD7B ADGRL3	4.53e-05	181	96	5	8dfb42d096db6c2df9b41303a7199d134d4bff07
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SLC12A1 CECR2 ARFGEF1 MERTK ITPR3	4.53e-05	181	96	5	22363c5835dd6cef8f895ab9362e0837d92b15b1
ToppCell	normal_Lung-Myeloid_cells-CD207+CD1a+_LCs\|Myeloid_cells / Location, Cell class and cell subclass	USP2 GPRC5C CCR6 ZNF439 PCDH10	4.65e-05	182	96	5	8dd79fef8f8463ad3194f9cc07c6cacf2c886304
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ANO2 ADAMTS6 SRPX ADGRL3 LIMS2	4.77e-05	183	96	5	c1297d8eddfc7132e84ceef14f01b6281f9d0f6a
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANO2 ADAMTS6 THSD7B ATP1B2 PCDH10	5.16e-05	186	96	5	fef543f188edb0d1704d9c6ace366a0f8017bf53
ToppCell	Control-Endothelial-Endothelial-Vein\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADAMTS6 TLN2 PCDH10 ADGRL3 LIMS2	5.16e-05	186	96	5	92092f11ecce22c14f244e42c499af0822977e6f
ToppCell	wk_20-22-Hematologic_Lymphocytic-B-CD5+_CCL22-_mature_B\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	ADAMTS6 IGHM KBTBD8 CCR6 SP140	5.16e-05	186	96	5	3941d4af5f2b209d71f59d7d920f2322131b4a0c
ToppCell	10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-naive_B_cell\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	ADAMTS6 IGHM CCR6 SP140 LIMS2	5.43e-05	188	96	5	31129152386e9aba16f749d78da12a08b916e6f8
ToppCell	3'-Adult-Distal_Rectal-Mesenchymal-Pericytes\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	USP2 STARD9 TLN1 MERTK ATP1B2	5.56e-05	189	96	5	d69b7a01dd4d6ad043bb6210e9ab34b49578389c
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SOX6 ADAMTS6 MERTK PCDH10 LIMS2	5.56e-05	189	96	5	c45734970036e6d28d5e3fe7c9458fae38a3f624
ToppCell	3'-Adult-Distal_Rectal-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	USP2 STARD9 TLN1 MERTK ATP1B2	5.56e-05	189	96	5	2b5f1b4f173a224342ea4f10b193ee33b7662699
ToppCell	3'-Adult-Distal_Rectal-Mesenchymal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	USP2 STARD9 TLN1 MERTK ATP1B2	5.56e-05	189	96	5	43e131458d8a4b120f7a5fb3d0c5650abded15f6
ToppCell	BAL-Control-Lymphocyte-B-B_cell\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	WDR91 ZNF608 IGHM MED12L ITPR3	5.70e-05	190	96	5	da7341a8a423e5fe4d8e733d8e50c10a3318ac1c
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Artery\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SOX6 ADAMTS6 MERTK PCDH10 LIMS2	5.70e-05	190	96	5	aed65d584ca0c25f6a8313c66b421a6618af82ea
ToppCell	BAL-Control-Lymphocyte-B-B_cell-B_cell\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	WDR91 ZNF608 IGHM MED12L ITPR3	5.70e-05	190	96	5	42312f7d79fe889397d32910b625793e2535cc26
ToppCell	BAL-Control-Lymphocyte-B-B_cell-B_cell-B_activate-7\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	WDR91 ZNF608 IGHM MED12L ITPR3	5.70e-05	190	96	5	682418a7a2096743112eae3790d40e7e600612c0
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Artery\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SOX6 ADAMTS6 MERTK PCDH10 LIMS2	5.85e-05	191	96	5	4b3d5157344dbfbf4fab518611cd9fa37fac7bd9
ToppCell	10x5'v1-week_17-19-Lymphocytic_B-B_lineage-naive_B_cell\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	ADAMTS6 IGHM CCR6 SP140 LIMS2	5.99e-05	192	96	5	5d6569b0f879729aa89d4498c9c886ac9050be13
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SOX6 ZNF608 ADAMTS6 THSD7B ATP1B2	5.99e-05	192	96	5	bf1943715085c4124b1675888b0615c9500ec888
ToppCell	10x_3'_v2v3-Non-neoplastic-Lymphoid-B_cell-B_cell-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ARID1B IGHM CCR6 AGAP9 SP140	6.30e-05	194	96	5	9a99abc65e7509e7ae8fb392f5ee4b2a83128072
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ANO2 ZNF608 ADAMTS6 ADGRL3 LIMS2	6.30e-05	194	96	5	71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ANO2 ADAMTS6 SRPX ADGRL3 LIMS2	6.30e-05	194	96	5	fc2e0081005c0c496e41197a2d06e4a37708221f
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ANO2 ZNF608 ADAMTS6 SYNE1 LIMS2	6.30e-05	194	96	5	40842a7160f337bfc191ee15fbda3e3d38a04c57
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NOTCH2NLB NOTCH2NLA SIRPB1 TNFAIP2 NOTCH2	6.30e-05	194	96	5	dfe0ece81922bfd7c6673726d3ea2365cbdb5513
ToppCell	Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_cell-B_mature\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ZCCHC18 ADAMTS6 IGHM CCR6 SP140	6.61e-05	196	96	5	4b9eb163b9dbbf5eebb160f6554f6f28cb234d31
ToppCell	PBMC-Control-cDC_3\|Control / Compartment, Disease Groups and Clusters	IPO5 ARFGEF2 AKAP11 NOTCH2 LRRC74B	6.61e-05	196	96	5	09d197b321ff9f13c0672ea059c850845b0dbbd5
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_2-AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	TKT FDPS SCP2 ALAS1 TMED3	6.77e-05	197	96	5	ad6f047d003c08413264f39a30ba0f7639a257cd
ToppCell	367C-Myeloid-Macrophage-FABP4+_Macrophage\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	SSU72 TKT PSMA4 SCP2 ALAS1	6.77e-05	197	96	5	07aee25e17dbb71e49f7da9fd9ed2537f4a72d82
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	USP2 ADAMTS6 STARD9 SYNE1 ADGRL3	6.77e-05	197	96	5	ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW19-Macroglial-Astrocyte\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	NOTCH2NLB ADAMTS6 RNF213 ATP1B2 NOTCH2	6.93e-05	198	96	5	bfad1c51cf884ff7ce89f8278820800582541dc7
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW19-Macroglial\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	NOTCH2NLB ADAMTS6 RNF213 ATP1B2 NOTCH2	6.93e-05	198	96	5	6372e65242236c497d9b3be147092897c1609d22
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SOX6 CCN6 NBEAL1 GPRC5C PTPRU	6.93e-05	198	96	5	b598ab958e31f1e98bd06dc0097b58ac3a3f90a3
ToppCell	LPS_only-Epithelial_alveolar-AT_2-AT2\|LPS_only / Treatment groups by lineage, cell group, cell type	TKT FDPS SCP2 ALAS1 TMED3	6.93e-05	198	96	5	6b6572deeca98ccb015f2aa3c5ce27de44445f74
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_2-AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	TKT FDPS SCP2 ALAS1 TMED3	6.93e-05	198	96	5	d12f37527399038a8f030b45b176bda5c7c8a7ad
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	USP2 ADAMTS6 STARD9 SYNE1 LIMS2	6.93e-05	198	96	5	22e766df1276c5b14aa0d83f434f47140ebb98ea
ToppCell	LPS_IL1RA-Epithelial_alveolar\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	TKT FDPS SCP2 ALAS1 TMED3	7.10e-05	199	96	5	5b140ac88ebc25ce397ae577e48f3e271faf46e7
ToppCell	Sepsis-Leuk-UTI-Lymphocyte-B-B_intermediate\|Leuk-UTI / Disease, condition lineage and cell class	ZNF608 ADAMTS6 IGHM CCR6 SP140	7.10e-05	199	96	5	e3edf3bcb381dbcf0092bdc2ee93ba852d32af3f
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ZNF608 MPDZ RNF213 ADGRL3 LIMS2	7.27e-05	200	96	5	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	Neuronal-Inhibitory\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SOX6 ZNF608 ADAMTS6 THSD7B ATP1B2	7.27e-05	200	96	5	9ff8647e2de0b538e15929dca88ebb20ff7ab043
ToppCell	Control_saline-Endothelial-Endothelial-Artery\|Control_saline / Treatment groups by lineage, cell group, cell type	SOX6 ADAMTS6 MERTK PCDH10 LIMS2	7.27e-05	200	96	5	65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Macroglial-Astrocyte\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	NOTCH2NLB ADAMTS6 RNF213 ATP1B2 NOTCH2	7.27e-05	200	96	5	7c66953ff6d8f16f4decd23c85232990d2d8c6c4
ToppCell	Control-Control-Lymphocyte-B-B_naive\|Control / Disease, condition lineage and cell class	ZNF608 IGHM APBB2 CCR6 SP140	7.27e-05	200	96	5	15e4b9956b9a0c2e6927a802e86e1cb4bb18b89a
ToppCell	Control_saline-Endothelial-Endothelial-Vein\|Control_saline / Treatment groups by lineage, cell group, cell type	ADAMTS6 TLN2 PCDH10 ADGRL3 LIMS2	7.27e-05	200	96	5	e5f876910bc8cb390d9b46a48d9b6d4d57235551
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Artery\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SOX6 ADAMTS6 MERTK PCDH10 LIMS2	7.27e-05	200	96	5	b1ff8d61b567f85006d6d20093f9c803b6d34674
ToppCell	Control-Classical_Monocyte-\|Classical_Monocyte / Disease condition and Cell class	AGAP5 MED12L RBKS ATP1B2	1.80e-04	130	96	4	4433b40b099845f113993b6ecf85ec594b4b9219
ToppCell	Severe-B_naive-8\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	ZNF608 IGHM APBB2 LIMS2	2.73e-04	145	96	4	a24cad86509208bc7267b02ef1d1b0a25a2a7043
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ANO2 ADAMTS6 SRPX LIMS2	3.11e-04	150	96	4	4f31867cb85253ff6d22f3b02ef972a42cb41123
ToppCell	Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CCN5 ZCCHC18 TLN2 PCDH10	3.35e-04	153	96	4	1524557514668f515ac1bbe847611f564b265b42
ToppCell	tumor_Lymph_Node_/_Brain-B_lymphocytes-Undetermined\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	ZCCHC18 IGHM CUL9 SP140	3.43e-04	154	96	4	e16f200391537aa1002b0079481b94e1fb86b9ad
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_B0\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	SOX6 CCN5 ADAMTS6 TNFAIP2	3.52e-04	155	96	4	a16e3a72badafa78a3efc4f4ab62396f0ce99d1e
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-12\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ZCCHC18 IGHM ZNF439 LIMS2	3.61e-04	156	96	4	7ece590fd8f29382e349dd0e5e016d2926aeb518
ToppCell	COVID-19_Moderate-multiplets\|World / disease group, cell group and cell class	SYNE1 IGHM RNF213 ITPR3	3.61e-04	156	96	4	afdc025fa75e7926b1cc182c4a33654a2186abb1
ToppCell	Control-Endothelial-Epi-like\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	WDR91 ACADS RBKS HARBI1	3.69e-04	157	96	4	4d02c50d5d1b892ea241e98724386d8a5a156a46
ToppCell	Control-Endothelial-Epi-like-Alv_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	WDR91 ACADS RBKS HARBI1	3.69e-04	157	96	4	2c369660c752c0fb3bd798a561d3359e2f9aa983
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-5\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CCN5 CLCN6 IGHM CCR6	3.78e-04	158	96	4	41cf950983f47a9e55d56041b301006b42853b37
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage\|356C / Donor, Lineage, Cell class and subclass (all cells)	ASGR1 WNT5A SIRPB1 HARBI1	3.87e-04	159	96	4	24f87c666eff10c1844c900ffd7ad49fa9f80481
ToppCell	356C-Lymphocytic-NK_cells-NK_cell_A2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	SOX6 AGAP5 ASGR1 TMPRSS11B	4.06e-04	161	96	4	8ec923c230a7a3cce5edf2a736b3a00d607c698a
ToppCell	Healthy_Control-Lymphoid-B-\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	ZCCHC18 IGHM MED12L CCR6	4.26e-04	163	96	4	d84bd41b4494c7d5c7f88d511bfe481fb12f079d
ToppCell	wk_08-11-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	STARD9 WNT5A RBKS THSD7B	4.26e-04	163	96	4	1e8730d75cccf7292010683ab4e81a69d8e3bfa9
ToppCell	Healthy_Control-Lymphoid-B\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	ZCCHC18 IGHM MED12L CCR6	4.26e-04	163	96	4	0f723ec2503afa1b3ebb0754972438ffb6e6179d
ToppCell	10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-immature_B_cell\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	ADAMTS6 IGHM SP140 LIMS2	4.36e-04	164	96	4	69b6566fb88c7449b7ab9056b57508cb6a1aa2af
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD4-Tregs\|bone_marrow / Manually curated celltypes from each tissue	IGLV3-12 CCN6 EVX1 CCR6	4.46e-04	165	96	4	1ae1ad4e1fe19b6eefff0f9a03d58a384f169759
ToppCell	LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells-B-cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IGHM KBTBD8 CCR6 SP140	4.77e-04	168	96	4	eeb381b62c7ba263af96de1194ed59e57b6ca3ae
ToppCell	LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IGHM KBTBD8 CCR6 SP140	4.77e-04	168	96	4	063d0368d656962b335154c230bdcd9236e7c9ad
ToppCell	Adult-Endothelial-endothelial_cell_of_artery-D122\|Adult / Lineage, Cell type, age group and donor	ANO2 SRPX PCDH10 LIMS2	4.77e-04	168	96	4	8c3e1e45b422813bcdfa4273b1167db649a312f5
ToppCell	LPS-IL1RA+antiTNF-Lymphocytic_B\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IGHM KBTBD8 CCR6 SP140	4.77e-04	168	96	4	a7c4251d8a83bc30196a444028a35c17c24dc291
ToppCell	3'-Adult-SmallIntestine-Hematopoietic-B_cells-Cycling_B_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADAMTS6 KBTBD8 MED12L SIRPB1	4.88e-04	169	96	4	203971cceeba150d0e8891c92662545e84c77837
ToppCell	facs-Tongue-nan-24m-Epithelial-nan\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCN5 TKT FDPS TNFAIP2	4.88e-04	169	96	4	0054f9bfd4d377c7fd94873c1308622051c59a8e
ToppCell	URO-Lymphocyte-B-B_intermediate\|URO / Disease, Lineage and Cell Type	ADAMTS6 IGHM CCR6 SP140	4.99e-04	170	96	4	e11d1510518cedabeece96d4adbb90999e6326fa
ToppCell	LPS-IL1RA-Lymphocytic_B-B_cells-B-cells\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IGHM KBTBD8 CCR6 SP140	4.99e-04	170	96	4	92e0873f618b2fa60c4d555b10f234d5cbcf3325
ToppCell	LPS-IL1RA-Lymphocytic_B-B_cells\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IGHM KBTBD8 CCR6 SP140	4.99e-04	170	96	4	c181991f933b779f99afc3782f292306f209e2ac
ToppCell	LPS-IL1RA-Lymphocytic_B\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IGHM KBTBD8 CCR6 SP140	4.99e-04	170	96	4	56284fbfd1e53f67c8c0b7fba64505a4002adba2
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZNF608 ADAMTS6 THSD7B ATP1B2	5.10e-04	171	96	4	a5634b76476b8b2488a706bbab5141f7bd94631f
ToppCell	facs-Marrow-T_cells-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNE1 ALAS1 PTPRU TMED3	5.10e-04	171	96	4	95e87987a2332fa646849fb0de785f1e0b8a07dd
ToppCell	facs-Marrow-T_cells-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNE1 ALAS1 PTPRU TMED3	5.10e-04	171	96	4	36657e277aad75c4f157c1726c48e09b5836cf37
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SOX6 ATP1B2 NOTCH2 LIMS2	5.10e-04	171	96	4	4ede831aed364cb5271f49a8b09bb6d0452f9b35
ToppCell	3'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-Immature_B\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGHM KBTBD8 CCR6 SP140	5.21e-04	172	96	4	0bcb960c5ab0d3cbbdf6235b6f28327ea60ba3e3
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-6_VIP_RGS16\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZNF608 ADAMTS6 WNT5A ATP1B2	5.21e-04	172	96	4	8b396d1e9173da104d467e42286379fe07cee257
ToppCell	E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	STARD9 CUL9 OPLAH TANGO6	5.21e-04	172	96	4	3b9be685fcd1634498a603b692f5ac6ddd0de176
ToppCell	droplet-Marrow-nan-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF608 SYNE1 ARFGEF1 XPO7	5.21e-04	172	96	4	d354424c1f861b6607dfd63b9724f4c237b30275
ToppCell	E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TMEM175 CCR5 TNFAIP2 SP140	5.32e-04	173	96	4	20f7dfe7d92a3dbec9da9a1f3185aa10cb8f0a3c
ToppCell	Mild/Remission-B_naive-8\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	ARID1B IGHM APBB2 LIMS2	5.32e-04	173	96	4	694d02c4d2dc2de4b344544f9124fec40fcf7d8f
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-5_VIP_KCNJ2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZNF608 ADAMTS6 THSD7B ATP1B2	5.44e-04	174	96	4	fdadac1eaab2c4a67e4832f0901df22e893add6a
ToppCell	Influenza_Severe-B_intermediate\|Influenza_Severe / Disease group and Cell class	IGHM MED12L CCR6 LIMS2	5.44e-04	174	96	4	4276bdaac53aebd3084323a90ecde572d3177446
ToppCell	LPS-antiTNF-Lymphocytic_B\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IGHM KBTBD8 CCR6 SP140	5.44e-04	174	96	4	cc493654ea3517bc6a145c7f787f304929636f86
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SOX6 ADAMTS6 WNT5A THSD7B	5.44e-04	174	96	4	cc4c7f00a25a7814b52d4599166615daa140cc31
ToppCell	LPS-antiTNF-Lymphocytic_B-B_cells-B-cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IGHM KBTBD8 CCR6 SP140	5.44e-04	174	96	4	9eb3504f9340517ef5d056503044fbdb9ffeb714
ToppCell	LPS-antiTNF-Lymphocytic_B-B_cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IGHM KBTBD8 CCR6 SP140	5.44e-04	174	96	4	b4c2d1c029fcd0d4926aa79a5b789c713919dcf3
Computational	Genes in the cancer module 8.	IPO5 ASGR1 FDPS PSMA4 SCP2 PRKDC IMMT SDHB ITPR3 TMED3	1.32e-04	421	62	10	MODULE_8
Computational	B lymphoma expression clusters.	SOX6 USP2 IGHM MED12L TNFAIP2 SP140	2.08e-04	149	62	6	MODULE_361
Computational	Genes in the cancer module 17.	FDPS SF3A1 PSMA4 SCP2 PRKDC IMMT SDHB ITPR3 TMED3	2.29e-04	366	62	9	MODULE_17
Computational	Neighborhood of DEAF1	PRKDC IMMT SDHB XPO7	3.15e-04	57	62	4	MORF_DEAF1
Computational	Neighborhood of PPP1CC	IPO5 PRKDC UQCRC1 IMMT SDHB XPO7	3.73e-04	166	62	6	MORF_PPP1CC
Computational	Genes in the cancer module 145.	SOX6 USP2 IGHM MED12L TNFAIP2	4.35e-04	111	62	5	MODULE_145
Computational	Neighborhood of CUL1	XPO6 PSMA4 IMMT XPO7	7.70e-04	72	62	4	MORF_CUL1
Computational	Neighborhood of CDC16	PRKDC IMMT SDHB XPO7	8.98e-04	75	62	4	MORF_CDC16
Computational	Genes in the cancer module 18.	IPO5 FDPS PSMA4 SRPX PRKDC ATP1B2 OGG1 ITPR3 TMED3	1.04e-03	451	62	9	MODULE_18
Computational	Genes in the cancer module 188.	SOX6 USP2 IGHM MED12L TNFAIP2	1.21e-03	139	62	5	MODULE_188
Disease	beta-hydroxybutyric acid measurement	THSD7B MERTK	1.37e-04	6	90	2	EFO_0010465
Disease	systolic blood pressure, alcohol consumption measurement	SOX6 CLCN6 EVX1	4.04e-04	47	90	3	EFO_0006335, EFO_0007878
Disease	cerebral palsy (implicated_via_orthology)	AGAP5 AGAP9	4.07e-04	10	90	2	DOID:1969 (implicated_via_orthology)
Disease	insulin sensitivity measurement, response to polyunsaturated fatty acid supplementation	TLN2 PTPRU	4.97e-04	11	90	2	EFO_0004471, EFO_0009131
Disease	obesity (implicated_via_orthology)	THADA MED12L SCP2 NOTCH2 ITPR3	5.21e-04	215	90	5	DOID:9970 (implicated_via_orthology)
Disease	unipolar depression, bipolar disorder	SOX6 ACADS STARD9 SYNE1	1.35e-03	156	90	4	EFO_0003761, MONDO_0004985
Disease	Headache, HbA1c measurement	NBEAL1 TKT	1.86e-03	21	90	2	EFO_0004541, HP_0002315
Disease	Hereditary Paraganglioma-Pheochromocytoma Syndrome	MERTK SDHB	2.23e-03	23	90	2	C1708353
Disease	Neoplasm Invasiveness	TKT TLN1 RECK NOTCH2	2.46e-03	184	90	4	C0027626

Protein segments in the cluster

Peptide	Gene	Start	Entry
SLSCQMAALQGNGSE	ASGR1	136	P07306
RNGLNCAAVMRVALS	FAM200B	626	P0CF97
ALQSIQNMRGNAHCV	AGAP9	511	Q5VTM2
AGNVSEAVQAACMLR	APBB2	691	Q92870
SRGCASTGVIMSVNN	ACADS	106	P16219
VVRCIAQMVNSQAAN	ARFGEF1	1256	Q9Y6D6
SQGTLACSASDQMRR	EVX1	171	P49640
IMSQRCNNRTQCAVV	ADGRL3	86	Q9HAR2
CIAQMVNSQAANIRS	ARFGEF2	1206	Q9Y6D5
VTAANLGKMNRSCQS	CCR6	276	P51684
GMNITVLRSQCDAAS	AKAP11	206	Q9UKA4
QLRCMQVGGNANATA	ARFGAP2	76	Q8N6H7
AAAVMQAAANSAQSR	ARID1B	1016	Q8NFD5
CSRANNTMGINSLIA	ANO2	291	Q9NQ90
LNNCSSSNRLDQAMQ	CCR5	266	P51681
NAMASLQGCETLNAA	CECR2	1261	Q9BXF3
SAQCGLGQQMRTVQC	ADAMTS6	1031	Q9UKP5
INRQSRTTCVNANMG	NBEAL1	476	Q6ZS30
KNRCQNGGTCVAQAM	NOTCH2NLA	31	Q7Z3S9
NALFSCISRNEMGSV	RECK	136	O95980
MQSRQVACTQQLSNG	ADAMTS19	996	Q8TE59
MLSSGASCAAAAQRN	ITPR3	1551	Q14573
TCSACRVQGRNADNM	KAT6B	271	Q8WYB5
LLNSVMGQRNCDCSV	LRRC9	586	Q6ZRR7
ANQCVQAARLGAMTS	RBKS	56	Q9H477
NRCQNGGTCVAQAML	NOTCH2NLB	71	P0DPK3
NRCQNGGTCVAQAML	NOTCH2	71	Q04721
MSDALANAVCQRCQA	LIMS2	6	Q7Z4I7
CENANTSLGRRMSVN	MED12L	666	Q86YW9
MNVTRNTAFNLTCQA	MERTK	206	Q12866
LAAQMNQRGSSVFCK	ALAS1	111	P13196
LCSSLRMNGDQNSDV	FDPS	61	P14324
GANQSMNVTCAGKRD	ATP1B2	191	P14415
SQASMSRCVANVTEA	HARBI1	96	Q96MB7
QVMSQRAISFAGCTA	OR2T7	76	P0C7T2
ANSIGAMNNSDTRIA	OR52B6	16	Q8NGF0
AMNNSDTRIAGCFLT	OR52B6	21	Q8NGF0
MLRACQLSGVTAAAQ	IMMT	1	Q16891
CSSNNNIARITGMVE	OGG1	146	O15527
VMSQRAISFAGCTAQ	OR2T27	86	Q8NH04
TNRAQSAGMDLFSNC	PCDH10	926	Q9P2E7
CGDTSLNNMQRQLAL	IPO5	266	O00410
KNRCQNGGTCVAQAM	NOTCH2NLC	31	P0DPK4
MAASVVCRAATAGAQ	UQCRC1	1	P31930
VATAQMARITCGGNN	IGLV3-12	31	A0A075B6K2
SNTNGCTQRLGMTAS	KBTBD8	271	Q8NFY9
NAGQNASFQCMAAGR	PTPRU	201	Q92729
ANSQVMGSANSTLRA	GPRC5C	396	Q9NQ84
RTCGMGISNRVTNEN	CCN6	221	O95389
GISNRVTNENSNCEM	CCN6	226	O95389
LGECRQMSSSSQIGN	CLCN6	396	P51797
HRGLTFQQNASSMCV	IGHM	201	P01871
TNCLAALANMSAQFR	DYM	461	Q7RTS9
TTCGLGMATRVSNQN	CCN5	206	O76076
LMLNTEGCSSAARNG	CUL9	856	Q8IWT3
NRSNKGAVGNCVTTM	CEP131	171	Q9UPN4
ATCIGNNSAAAVSML	PSMA4	161	P25789
GAQALCAALTVNQAM	LRRC74B	151	Q6ZQY2
QGRQFCSTQAALQAM	NUMA1	956	Q14980
LGRQQAMAQSLSQCS	OTP	226	Q5XKR4
ISSCMENFNLGRASV	THADA	141	Q6YHU6
VNSRMGCQATQLTSR	SYNE1	3671	Q8NF91
ACAASQGCMNNVTLG	OPLAH	1096	O14841
NDTIISGMNCNGSAA	SLC12A1	446	Q13621
QGLTLSNVARCSSMD	STARD9	3501	Q9P2P6
TCAAMNVNVGVRTAA	SRPX	316	P78539
NNNCATGSTALFMAR	SCP2	91	P22307
SGSMARTQQAAQANI	SF3A1	506	Q15459
LSSINNMGLNSCRNE	SOX6	526	P35712
ALQSIQNMRGNAHCV	AGAP5	466	A6NIR3
NNCISMLVAGNDRVQ	TRIM63	171	Q969Q1
PMRAENQANVTCQVS	SIRPB1	261	O00241
QSAVGMLRDQNESCT	RNF213	3541	Q63HN8
NVIANINNCLSFRMS	TNFAIP2	421	Q03169
AGEGIQCSQRMLSFS	TMEM175	26	Q9BSA9
AGMSSEQVAQVLRQC	MPDZ	311	O75970
AASEMLTNNCCGRQV	TMPRSS11B	161	Q86T26
EQNMVSIAVGCATRN	TKT	366	P29401
RMAAISESNINLCGS	TKT	401	P29401
QFARANQAIQMACQS	TLN1	1466	Q9Y490
GNRVTALTQMESACV	TMED3	131	Q9Y3Q3
MAARQAVGSGAQETC	TANGO6	1	Q9C0B7
NESVSRAMCALLNSG	SLFN12	41	Q8IYM2
VSAAGVVNAMSRACR	WNT5A	141	P41221
MNGILAQDSACSQRA	PRKDC	3771	P78527
MASITACVGNSRQQN	ZCCHC18	1	P0CG32
VASQQVAAQASASGM	ZNF608	1491	Q9ULD9
LGINNQSNLTDMRCR	XPO7	651	Q9UIA9
GSSMAQLLTCAAQGN	TLN2	1101	Q9Y4G6
QACGTMDTVDIANNS	SP140	476	Q13342
TLQCAGNRRSEMTQV	SUOX	261	P51687
TRQVSCTRSDGQNAM	THSD7B	301	Q9C0I4
ARKMASVNGSSQNCV	XPO6	286	Q96QU8
CAMNINGGNTLACTR	SDHB	101	P21912
LAGLRNLGNTCFMNS	USP2	266	O75604
ELAMVCSQRNASLSQ	WDR91	241	A4D1P6
LRVAVVCSSNQNRSM	SSU72	6	Q9NP77
ALRNDSACNPVMATQ	ZP4	216	Q12836
CEVGLGNSSSNMNIR	ZNF439	126	Q8NDP4